176
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Ongoing excellent outcomes with reduced toxicities following integration of molecular targeted therapies in pediatric anaplastic large cell lymphoma

, , , , , , , , , , , , & show all
Pages 1995-1999 | Received 04 Nov 2020, Accepted 14 Feb 2021, Published online: 08 Mar 2021
 

Acknowledgements

The authors to acknowledge all the staff involved in the care of these patients and of course the patients and families themselves.

Disclosure statement

The authors report no conflict of interest.

Data availability statement

The data that support the findings of this study are available on request from the corresponding author, OS. The data are not publicly available due to their containing information that could compromise the privacy of research participants.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.